Literature DB >> 11573554

Clinical characteristics, pulmonary function abnormalities and outcome of prednisolone treatment in 106 patients with sarcoidosis.

S K Sharma1, A Mohan, J S Guleria.   

Abstract

The clinical profile of one hundred and six biopsy proved patients with sarcoidosis is reported from New Delhi. The disease occurred more frequently in males (68 of the 106; 64%) in their fifth decade. Dry cough (83%), exertional dyspnoea (61%), fever (56%) and joint pains (44%) were frequent symptoms. Hepatomegaly (45%), peripheral lymphadenopathy (45%), cutaneous involvement (42%), presence of crepitations (36%) were frequent signs. In addition, ocular symptoms (18%), parotid gland enlargement (12%), facial nerve palsy (8%) were observed. Audible wheeze was present in nine patients. Radiologically, 25 (24%), 67 (63%) and 14 (13%) of patients belonged to stage I, II and III respectively at presentation. More than one sibling was involved in six families. Pulmonary functions revealed mixed obstructive and restrictive ventilatory defect. However, obstructive ventilatory defect was predominant. Systemic steroids were used in 81 patients who regularly followed up. Frequent relapses occurred on tapering off or stopping the corticosteroids in 21 patients. History of malaise (p < 0.05), presence of crepitations (p < 0.05), wheezing (p < 0.05), peripheral blood eosinophilia (p < 0.05) and FEV1/FVC (%) < 65% of the predicted value (p < 0.05), were independent predictors of relapse. Hyperuricaemia, hitherto unreported in patients with sarcoidosis was observed in 41% of patients for whom values were available. Two patients died; one from cardiomyopathy and another from stroke. In summary, constitutional symptoms such as fever, weight loss and pulmonary infiltrates, were more frequently encountered in Indian patients with sarcoidosis as compared to western studies. A high index of clinical suspicion and histopathological confirmation early in the illness are required to ascertain the diagnosis lest these patients will get treated as tuberculosis with potentially hepatotoxic drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11573554

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  7 in total

1.  Skeletal muscle weakness in patients with sarcoidosis and its relationship with exercise intolerance and reduced health status.

Authors:  M A Spruit; M J Thomeer; R Gosselink; T Troosters; A Kasran; A J T Debrock; M G Demedts; M Decramer
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

2.  Characteristics and Long-Term Outcome of Neurosarcoidosis: A Population-Based Study from 1976-2013.

Authors:  Patompong Ungprasert; Cynthia S Crowson; Eric L Matteson
Journal:  Neuroepidemiology       Date:  2017-06-10       Impact factor: 3.282

Review 3.  Neurosarcoidosis: Phenotypes, Approach to Diagnosis and Treatment.

Authors:  Jeanne Gosselin; Chantal Roy-Hewitson; Sean S M Bullis; John C DeWitt; Bruno P Soares; Sidarth Dasari; Alana Nevares
Journal:  Curr Rheumatol Rep       Date:  2022-10-12       Impact factor: 4.686

Review 4.  Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-alpha levels in Asian Indians.

Authors:  S Sharma; B Ghosh; S K Sharma
Journal:  Clin Exp Immunol       Date:  2007-12-06       Impact factor: 4.330

5.  Rare manifestations of sarcoidosis in modern era of new diagnostic tools.

Authors:  Surendra K Sharma; Manish Soneja; Abhishek Sharma; Mehar C Sharma; Smriti Hari
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

6.  Clinical Profile of 327 patients with Sarcoidosis in India: An Ambispective Cohort Study in a Tuberculosis (TB) Endemic Population.

Authors:  Karan Madan; P B Sryma; Bijay Pattnaik; Saurabh Mittal; Pawan Tiwari; Vijay Hadda; Anant Mohan; Randeep Guleria
Journal:  Lung India       Date:  2022 Jan-Feb

7.  Diagnosis and Detection of Sarcoidosis. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Elliott D Crouser; Lisa A Maier; Kevin C Wilson; Catherine A Bonham; Adam S Morgenthau; Karen C Patterson; Eric Abston; Richard C Bernstein; Ron Blankstein; Edward S Chen; Daniel A Culver; Wonder Drake; Marjolein Drent; Alicia K Gerke; Michael Ghobrial; Praveen Govender; Nabeel Hamzeh; W Ennis James; Marc A Judson; Liz Kellermeyer; Shandra Knight; Laura L Koth; Venerino Poletti; Subha V Raman; Melissa H Tukey; Gloria E Westney; Robert P Baughman
Journal:  Am J Respir Crit Care Med       Date:  2020-04-15       Impact factor: 21.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.